Addressing variability in iPSC-derived models of human disease: guidelines to promote reproducibility
Induced pluripotent stem cell (iPSC) technologies have provided in vitro models of inaccessible human cell types, yielding new insights into disease mechanisms especially for neurological disorders. However, without due consideration, the thousands of new human iPSC lines generated in the past decad...
Saved in:
Main Authors: | Viola Volpato (Author), Caleb Webber (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ergothioneine-Mediated Neuroprotection of Human iPSC-Derived Dopaminergic Neurons
by: Damien Meng-Kiat Leow, et al.
Published: (2024) -
Retinoic acid promotes barrier functions in human iPSC-derived intestinal epithelial monolayers
by: Shigeru Yamada, et al.
Published: (2019) -
Potential of iPSC-Derived Mesenchymal Stromal Cells for Treating Periodontal Disease
by: K. Hynes, et al.
Published: (2018) -
Lipidomic profiling of patient-specific iPSC-derived hepatocyte-like cells
by: Mostafa Kiamehr, et al.
Published: (2017) -
Neurosphere Based Differentiation of Human iPSC Improves Astrocyte Differentiation
by: Shuling Zhou, et al.
Published: (2016)